0102030405
01 eeg faahfaahinta
Daawooyinka Xadgudubka (DOA)
2022-09-06
- Lagu dabaqi karo meelo kala duwan, oo ay ku jiraan baaritaanka aashitada nucleic, cudurada faafa, xadgudubka daroogada, caafimaadka haweenka, iwm.
- Isticmaalka fudud, natiijooyinka waa la akhrin karaa iyada oo aan la tijaabin qalabka.
01 eeg faahfaahinta
CAAFIMADKA HAWEENKA
2022-09-06
- Lagu dabaqi karo meelo kala duwan, oo ay ku jiraan baaritaanka aashitada nucleic, cudurada faafa, xadgudubka daroogada, caafimaadka haweenka, iwm.
- Isticmaalka fudud, natiijooyinka waa la akhrin karaa iyada oo aan la tijaabin qalabka.
01 eeg faahfaahinta
Cudurka faafa
2022-09-06
- Lagu dabaqi karo meelo kala duwan, oo ay ku jiraan baaritaanka aashitada nucleic, cudurada faafa, xadgudubka daroogada, caafimaadka haweenka, iwm.
- Isticmaalka fudud, natiijooyinka waa la akhrin karaa iyada oo aan la tijaabin qalabka.
01 eeg faahfaahinta
COVID19 Ag (Dahab Colloidal)
2021-08-28
- Xirmooyinka tijaabada degdega ah ee COVID19 Antigen waa immunochromatography dahab kolloidal ah oo loogu talagalay in lagu ogaado antigens-ka borotiinka ee la soo saaray ee u gaarka ah COVID19. Tijaabada daryeelka degdega ah waxay mararka qaarkood noqon kartaa ikhtiyaarka kaliya ee la heli karo haddii baaritaanka shaybaadhka aan si ku filan loo heli karin. Intaa waxa dheer, xirmooyinka tijaabada degdega ah ee COVID19 Antigen waa shaybaar bilaash ah, oo u oggolaanaya in lagu baaro meelaha miyiga/kaabayaasha hoose.
01 eeg faahfaahinta
COVID-19 NAB (Dahab Colloidal)
2021-08-30
- Baaritaanka baaritaanka kahor tallaalka
- Natiijooyinka la socodka tallaalka ka dib
- Qiimaynta khatarta ah infekshanka labaad ee dadka cudurka qaba
- Qiimaynta khatarta ah ee dadka caadiga ah (ay ku jirto caabuqa asymptomatic) suurtagalnimada infekshanka
- Baaritaanka awoodda iska caabbinta fayraska